Xu Zi-Yan, Huang Jin-Jian, Liu Ye, Zhao Yun, Wu Xiu-Wen, Ren Jian-An
Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, Jiangsu Province, China.
Medical School, Southeast University, Nanjing 210009, Jiangsu Province, China.
World J Stem Cells. 2021 Oct 26;13(10):1564-1579. doi: 10.4252/wjsc.v13.i10.1564.
The development of "mini-guts" organoid originates from the identification of Lgr5 intestinal stem cells (ISCs) and circumambient signalings within their specific niche at the crypt bottom. These self-renewing "mini-guts", also named enteroids or colonoids, undergo perpetual proliferation and regulated differentiation, which results in a high-performance, self-assembling and physiological organoid platform in diverse areas of intestinal research and therapy. The triumphant reconstitution of ISC niche also relies on Matrigel, a heterogeneous sarcoma extract. Despite the promising prospect of organoids research, their expanding applications are hampered by the canonical culture pattern, which reveals limitations such as inaccessible lumen, confine scale, batch to batch variation and low reproducibility. The tumor-origin of Matrigel also raises biosafety concerns in clinical treatment. However, the convergence of breakthroughs in cellular biology and bioengineering contribute to multiform reconstitution of the ISC niche. Herein, we review the recent advances in the microfabrication of intestinal organoids on hydrogel systems.
“迷你肠道”类器官的发展源于对Lgr5肠道干细胞(ISC)及其在隐窝底部特定微环境中的周围信号的识别。这些自我更新的“迷你肠道”,也被称为肠类器官或结肠类器官,经历持续增殖和调控分化,从而在肠道研究和治疗的不同领域形成了一个高性能、自组装且具有生理功能的类器官平台。ISC微环境的成功重建还依赖于基质胶,一种异质性肉瘤提取物。尽管类器官研究前景广阔,但其广泛应用受到传统培养模式的阻碍,这种模式存在诸如难以形成管腔、规模受限、批次间差异以及低重复性等局限性。基质胶的肿瘤源性在临床治疗中也引发了生物安全问题。然而,细胞生物学和生物工程学的突破共同促成了ISC微环境的多种形式重建。在此,我们综述了水凝胶系统上肠道类器官微制造的最新进展。